Yayın:
Evaluation of antidepressant-like effect of 2-pyrazoline derivatives

dc.contributor.authorÖZDEMİR, AHMET
dc.contributor.authorTuran‐Zitouni, Gülhan
dc.contributor.authorAhmet Özdemır
dc.contributor.authorGülhan Turan‐Zitouni
dc.contributor.orcid0000-0003-0280-5550
dc.contributor.orcid0000-0002-9513-7661
dc.date.accessioned2025-11-13T09:56:47Z
dc.date.issued2009-03-17
dc.identifier.doihttps://doi.org/10.1007/s00044-009-9176-x
dc.identifier.endpage101
dc.identifier.issn1054-2523
dc.identifier.issue1
dc.identifier.openalexW2101701639
dc.identifier.startpage94
dc.identifier.urihttps://hdl.handle.net/11421/2682
dc.identifier.urihttps://doi.org/10.1007/s00044-009-9176-x
dc.identifier.volume19
dc.language.isoen
dc.relation.ispartofMedicinal Chemistry Research
dc.rightsrestrictedAccess
dc.subjectPyrazoline
dc.subjectAntidepressant
dc.subjectChemistry
dc.subjectClomipramine
dc.subjectBehavioural despair test
dc.subjectPharmacology
dc.subjectTranylcypromine
dc.subjectMedicinal chemistry
dc.subjectBiochemistry
dc.subjectMedicine
dc.subjectInternal medicine
dc.subjectMonoamine oxidase
dc.subjectHippocampus
dc.subject.sdg3
dc.titleEvaluation of antidepressant-like effect of 2-pyrazoline derivatives
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5100651829
local.authorid.openalexA5046700148

Dosyalar

Koleksiyonlar